Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 74 (RN7SKP74) is annotated as a pseudogene corresponding to the 7SK small nuclear RNA gene (RN7SK)[2][4]. Pseudogenes are typically non-functional copies of genes, often lacking the ability to encode functional RNA or protein. RN7SK itself codes for a long non-coding RNA involved in negative regulation of transcription elongation by RNA polymerase II as part of the 7SK small nuclear ribonucleoprotein (snRNP) complex, but RN7SKP74 does not encode a functional product and is not believed to play a biological role or serve as a drug target[2][4]. RN7SKP74 is a non-functional, non-coding RNA pseudogene derived from the 7SK snRNA gene, with no evidence of biological activity, therapeutic potential, or disease involvement[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 74 (RN7SKP74).